Correlation Between SynCore Biotechnology and Xander International

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SynCore Biotechnology and Xander International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SynCore Biotechnology and Xander International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SynCore Biotechnology Co and Xander International, you can compare the effects of market volatilities on SynCore Biotechnology and Xander International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SynCore Biotechnology with a short position of Xander International. Check out your portfolio center. Please also check ongoing floating volatility patterns of SynCore Biotechnology and Xander International.

Diversification Opportunities for SynCore Biotechnology and Xander International

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between SynCore and Xander is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding SynCore Biotechnology Co and Xander International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xander International and SynCore Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SynCore Biotechnology Co are associated (or correlated) with Xander International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xander International has no effect on the direction of SynCore Biotechnology i.e., SynCore Biotechnology and Xander International go up and down completely randomly.

Pair Corralation between SynCore Biotechnology and Xander International

Assuming the 90 days trading horizon SynCore Biotechnology Co is expected to generate 0.82 times more return on investment than Xander International. However, SynCore Biotechnology Co is 1.23 times less risky than Xander International. It trades about -0.04 of its potential returns per unit of risk. Xander International is currently generating about -0.29 per unit of risk. If you would invest  3,685  in SynCore Biotechnology Co on August 27, 2024 and sell it today you would lose (55.00) from holding SynCore Biotechnology Co or give up 1.49% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

SynCore Biotechnology Co  vs.  Xander International

 Performance 
       Timeline  
SynCore Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SynCore Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Xander International 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Xander International are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Xander International may actually be approaching a critical reversion point that can send shares even higher in December 2024.

SynCore Biotechnology and Xander International Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SynCore Biotechnology and Xander International

The main advantage of trading using opposite SynCore Biotechnology and Xander International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SynCore Biotechnology position performs unexpectedly, Xander International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xander International will offset losses from the drop in Xander International's long position.
The idea behind SynCore Biotechnology Co and Xander International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities